125. Andersson S., Gundersen P. M., Finset A. Emotional activation during therapeutic interaction in traumatic brain injury: effect of apathy, self-wareness and implications for rehabilitation // Brain Inj. 1999. Vol.13 (6). P.393–404.
126. Andreasen N. C. Symptoms, signs, and diagnosis of schizophrenia // Lancet. 1995. Vol. 346 (8973). P.477–481.
127. Angst J. How recurrent and predictable is depressive illness? // Long-term treatment of depression / S. Montgomery, F. Rouillon (Eds.). NY: John Willey, 1992.P.1–13.
128. Angst J. Aetiologie und Nosology endogener Depressionen. Berlin: Springer-Verlag, 1966.
129. Angst J., Dobler-Mikola A. The Zurich study: A continuum from depression to anxiety disorders? // Eur. Arch. Psychiat. Neurol. Sci. 1985. Vol.235. №.3. P.179–186.
130. Bleuler E. Dementia praecox oder Gruppe der Schizophrenien. Leipzig: Franz Deuticke, 1911.
131. Canadian Psychiatric Association. Clinical Guidelines for the treatment of depressive disorders // Can. J. Psychiatry. 2001. Vol. 46. Suppl. 1. P. 1–90.
132. Carpenter W. T., Heinrichs D. W., Alphs L. D. Treatment of negative symptoms // Schizophr. Bull. 1985. Vol.11 (3). P.440–452.
133. Cassano G. B., Musetti L., Perugi G. et al. A proposed new approach to the clinical subclassification of depressive illness // Pharmacopsychiatry. 1988. Vol. 21 (1). P.19–23.
134. Choi S. H., Na D. L., Kwon H. M. et al. The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients // J. Korean Med. Sci. 2000. Vol.15 (6). P.609–615.
135. Claxton A. J., Li Z., McKendrick J. Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression // Br. J. Psychiatry. 2000. Vol. 177. P. 163–168.
136. Conrad K. The problem of «nosological unity» in psychiatry // Nervenarzt. 1959. Vol.30. P.488–494.
137. Cowen P. J. Pharmacological management of treatment-resistant depression // Adv. Psychiatr. Treatment. 1998. Vol. 4. P. 320–327.
138. Danzon M. Mental health: facing the challenges, building solutions: report from the WHO European Ministerial Conference, 2006.
139. Deniker P. Clinical forms & diagnosis of thymic psychoses; questionnaire // Encephale. 1957. Vol.46 (1). P.19–25.
140. Depont F., Rambelomanana S., Puil S. et al. Antidepressants: psychiatrists’ opinions and clinical practice // Acta Psychiatr. Scand. 2003. Vol. 108. P. 24–31.
141. Derouesne C., Lacomblez L. Depression and dementia // Psychol. Neuropsychiatr. Vieil. 2004. Vol.2. Suppl.1. P.35–42.